Immunocore Holdings plc - American Depositary Shares — Cash Flow (NASDAQ:IMCR) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities ———2.94 M26.06 M-10.71 M -10.71 M Cash from investing activities ———-5.42 M-355.13 M-16.34 M -16.34 M Cash from financing activities ———34.35 M343.88 M12.37 M 12.37 M Free cash flow ———-2.48 M20.89 M-15.05 M -15.05 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Haberler

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Jefferies, rakip verisi öncesi Immunocore hissesi için Tut tavsiyesini korudu

Jefferies, gelir endişeleriyle Immunocore hissesini düşürdü

Jefferies downgrades Immunocore stock rating on revenue concerns

Immunocore Leerink Konferansı: Stratejik Büyüme ve İnovasyon

Immunocore at Leerink Conference: Strategic Growth and Innovation

Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25

Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript

Immunocore Holdings kazancı $0,40 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up